Successful treatment with thalidomide for pemphigus vulgaris.

Bingjie ZhangXuming MaoWenling ZhaoHongzhong JinLi Li

Published in: Therapeutic advances in chronic disease (2020)

These results demonstrate that thalidomide could be an effective and safe option for PV patients, especially those who are concerned about steroid-induced severe complications, and have mucosal diseases.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
high glucose
drug induced
early onset
patient reported outcomes
endothelial cells
stress induced